CD8A and neoplasm: The inactivation of Regnase-1 encoding alleles by sgRNA/Cas9 targeting resulted in a profound improvement of anti-tumor responses (57, 58), while aspects of CD8+ T cell biology had not been studied for Roquin-1, yet.